Drug supply in Nigeria

Area of Science:

• Public Health
• Tropical Medicine
• Health Economics

Background:

• Nigeria faces high childhood and maternal mortality, characteristic of tropical Africa.
• Prevalent diseases include malaria, measles, polio, and respiratory infections, alongside neglected tropical diseases like filariasis and schistosomiasis.
• Socioeconomic factors hinder optimal use of available medical technologies and drugs.

Purpose of the Study:

• To evaluate the impact of the World Health Organization's Essential Drug Programme and the Bamako Initiative on drug availability in Nigeria.
• To address challenges in drug supply chains and affordability in resource-limited settings.

Main Methods:

• Analysis of the implementation and outcomes of the Essential Drug Programme and Bamako Initiative in Nigeria.
• Assessment of drug availability and supply chain improvements in primary healthcare facilities.

Main Results:

• The Essential Drug Programme and Bamako Initiative have significantly improved drug availability in Nigeria.
• These programs aim to ensure affordable access to essential medicines for the majority of the population.
• Proceeds from drug sales are reinvested into healthcare services and stock replenishment.

Conclusions:

• The implemented drug programs show promise in improving Nigeria's health situation.
• Sustainable drug supply and affordability are crucial for combating prevalent diseases and reducing mortality.
• Continued support and effective management of these initiatives are vital for long-term health gains.